Adverse Drug Reactions Advisory Committee - Australian Drug Evaluation Committee, Australia, British Overseas Territories
von Alphascript Publishing
inklusive MwSt. - GRATIS LIEFERUNG
Dir gefällt dieses Produkt? Sag's weiter!
€ 39,00 inkl. USt.
Nur noch 1 Stück verfügbar Nur noch 1 Stück verfügbar
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. The Adverse Drug Reactions Advisory Committee or ADRAC is a subcommittee of the Australian Drug Evaluation Committee (ADEC) which monitors the safety of medicines in Australia. ADRAC evaluates reports from the Adverse Drug Reactions Unit of the Therapeutic Goods Administration (TGA), which administers the adverse drug reaction (ADR) reporting system in Australia, and may make recommendations regarding the medication including withdrawal of medications from the market. ADRAC also publishes the Australian Adverse Drug Reactions Bulletin to raise awareness of medication safety issues and ADR reports.The Therapeutic Goods Administration (TGA) is the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia. It is a Division of the Australian Department of Health and Ageing established under the Therapeutic Goods Act 1989 (Cth).
0.23 x 0.15 x 0.01 m; 0.168 kg